In short. Lifting, whole-face change in one session, durability and equal safety across skin types: the claims the evidence does not carry, and why they keep appearing.

Key points

  • The claim that improvement continues for months is graded limited rather than unsupported, because remodelling does continue for a time after the injury.
  • Limited still means it cannot carry a plan.
  • A patient deciding whether to spend money and healing days deserves an answer about what will have changed by a stated date.

A claim audit is more useful than a list of benefits, so this guide sets out what the evidence does not carry. Every claim below is one a patient is likely to meet, and none survives contact with the published record.

That plasma replaces a facelift

Not supported, and there is no approved indication for it. An operation repositions tissue and removes skin; a surface treatment does neither, and no setting changes that. Where the finding is descent, a device is not a smaller version of the operation. It is a treatment for a different problem, and offering it as a substitute is the most consequential error made about this treatment.

That one session tightens the whole face

Not supported. An injury extensive enough to produce visible tightening across an entire face in one pass would produce a wound rather than a result, and the healing would be correspondingly severe. Where a whole-face effect is claimed from one session, the claim describes the marketing rather than the mechanism.

That durability is established

Not established, and rarely measured. Follow-up in the published work is usually months rather than years, so a statement about how long a result lasts is an extrapolation from the mechanism rather than a finding. Because remodelling ends and the skin continues to age, a claim of lasting change is a claim nobody has tested.

Limited is not the same as reasonable to rely on

The claim that improvement continues for months is graded limited rather than unsupported, because remodelling does continue for a time after the injury. Limited still means it cannot carry a plan. A patient deciding whether to spend money and healing days deserves an answer about what will have changed by a stated date.

That darker skin is treated as safely as lighter skin

Not supported as a general claim. Any resurfacing injury can leave treated skin darker or lighter than it was, and that risk is higher in skin that tans readily or has marked after a previous injury. This does not make treatment impossible or unmanageable. It means the treatment is a decision taken after a skin examination, often with a small test area first, rather than an item offered on the same terms to everyone.

That the collagen finding settles the question

Not established, and this claim does the most work in advertising. New collagen forming during healing is well described. The step from that finding to a change in the position of the face is an inference, and the amount formed has not been established as sufficient to produce such a change. A description of healing presented as a description of a result does not become true through repetition.

Treat with caution if

  • Anyone tells you a plasma treatment will lift your face — that claim has no approved indication behind it and is not supported by the evidence.
  • Anyone attributes a lasting result to new collagen without stating when the result will be judged.
  • Anyone describes the treatment as equally safe on every skin type without examining yours.

Related reading

Frequently asked questions

Is it true that plasma tightens a whole face in one session?

No. Not supported. An injury extensive enough to produce visible tightening across a whole face in a single pass would produce a wound rather than a result, and the healing would be correspondingly severe. Treatment is normally delivered as more than one session spaced several weeks apart, and the result is judged months after the last one.

How long does a plasma result last?

This is not established, and it is rarely measured. Follow-up in the published work is usually months rather than years, so any statement about durability is an extrapolation from the mechanism rather than a finding. A provider who answers this question with confidence is answering from the mechanism rather than from evidence.

Does a collagen finding prove the treatment tightens skin?

No. New collagen after an injury is well described and measurable. The step from that finding to a change in the position of the face is an inference, and the amount formed has not been established as sufficient to produce such a change. A description of healing presented as a description of a result is the commonest overstatement in this field.

Risks & Limitations

  • Plasma treatment acts on the surface of the skin. Tightening the skin is not a lift and does not reposition tissue that has descended.
  • Pigment change is the central risk. Any resurfacing injury can leave treated skin darker or lighter, and the risk is higher in skin that tans readily or marks after injury.
  • The change may settle over months and may not settle completely.
  • New collagen forms as part of healing, but the amount formed is not established as enough to change the position of the face.
  • Infection, delayed healing and a scar that heals thickly or spreads are the ordinary risks of any wound.
  • The most common disappointing outcome is not a complication: it is days of healing for a change too small to be worth them.
  • This site is an evidence review rather than a booking page, and it does not state what Chongqing West District Hospital offers in relation to plasma treatment.

When to Seek Care

  • After a resurfacing treatment, blistering, spreading redness, warmth or pus suggests infection and needs assessment.
  • A treated area that is becoming more painful rather than less, or a wound that is not closing on the expected course, needs review.
  • Any treatment close to the eye that leaves pain, a change in vision or a lid that will not close — seek emergency care immediately.
  • A treated area that heals darker or lighter than the surrounding skin should be assessed rather than treated again.
  • A fever, or a rash spreading beyond the treated area, needs medical assessment rather than cosmetic advice.

References & Further Reading

  • U.S. Food and Drug Administration (FDA) — medical device clearances and their stated intended use
  • Medicines and Healthcare products Regulatory Agency (MHRA, UK) — medical device guidance
  • National Medical Products Administration (NMPA, China) — medical device registration
  • Cochrane Library — systematic reviews on skin resurfacing and skin tightening
  • Chinese Medical Association Plastic Surgery Branch — clinical guidance

Medically reviewed by Ke He, MD (何锞), Deputy Director & Head of Skin & Laser Aesthetics. Last reviewed: 19 September 2026.

This page is patient education, not medical advice, and it does not cite individual studies. It is an evidence review rather than a booking page. Discuss your own case with a qualified clinician; to ask a question about the content of this review, see Contact & Consultation.